Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05853972.7Aexternal-prioritypatent/EP1827483B1/en
Application filed by Swedish Orphan Biovitrum Ab (Publ)filedCriticalSwedish Orphan Biovitrum Ab (Publ)
Publication of CY1115607T1publicationCriticalpatent/CY1115607T1/el
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μακροχρόνιες σταθερές φαρμακοτεχνικές μορφές λυοφιλοποιημένου τελεστή αύξησης κερατινοκυττάρων και μεθόδους παρασκευής λυοφιλοποιημένης σύνθεσης που να περιλαμβάνει τελεστή αύξησης κερατινοκυττάρων.
fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat